$BVS Balance Sheet | Understand Stock

$BVS

$14.42 -$0.30 (2.04%) Close

$BVS Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Condensed Balance Sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 27, 2026	Q1 FY2026 As of Mar 28, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 27, 2025	Q2 FY2025 As of Jun 28, 2025	Q1 FY2025 As of Mar 29, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 28, 2024	Q2 FY2024 As of Jun 29, 2024	Q1 FY2024 As of Mar 30, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jul 1, 2023	Q1 FY2023 As of Apr 1, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Oct 1, 2022	Q2 FY2022 As of Jul 2, 2022	Q1 FY2022 As of Apr 2, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Oct 2, 2021
Assets
Current assets:
Cash and cash equivalents
Restricted cash
Accounts receivable, net
Inventory
Prepaid and other current assets
Current assets attributable to discontinued operations
Assets held for sale
Total current assets

Restricted cash, less current portion
Property and equipment, net
Goodwill
Intangible assets, net
Operating lease assets
Deferred tax assets
Investment and other assets
Long-term assets attributable to discontinued operations
Total assets

Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable
Accrued liabilities
Accrued equity-based compensation
Current portion of long-term debt
Current portion of deferred consideration
Current portion of contingent consideration
Other current liabilities
Current liabilities attributable to discontinued operations
Liabilities held for sale
Total current liabilities

Long-term debt, less current portion
Accrued equity-based compensation, less current portion
Deferred income tax liabilities
Deferred consideration, less current portion
Contingent consideration
Other long-term liabilities
Long-term liabilities attributable to discontinued operations
Total liabilities
Stockholders’ Equity
Common stock, value
Common Class A
Common Class B
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive loss
Total stockholders’ equity attributable to Bioventus Inc.
Noncontrolling interest
Total stockholders’ equity
Total liabilities and stockholders’ equity

Comments